Evaluation of TP53 codon 72 polymorphism in esophageal cancer susceptibility in Eastern Anatolia Region of Turkey

The tumor suppressor TP53 gene plays a key role in the regulation of cell cycle. Polymorphisms in this gene have beenassociated with many cancers including esophageal cancer (EC). Many studies in other populations have demonstrated thatcodon 72 polymorphism of TP53 gene contribute to the prediction of EC risk, especially in Asians. The aim of this studywas to explore the effect of codon 72 polymorphism on the EC risk in eastern Turkey.The codon 72 polymorphism was genotyped by real time polymerase chain reaction (qPCR) with TaqMan SNP geno typingassay in 79 patients and 80 healthy control subjects.No statistically significant difference was observed in distribution of genotype and allele frequencies. HeterozygousArg/Pro (CG) was the most frequent genotype in both patients and controls. Homozygous Arg/Arg (GG) genotypefrequency was higher in patients than controls, but not statistically signific ant (p>0.05). However, tumor location in thelower part of the esophagus was significantly higher in non-C carriers (GG, Arg/Arg) compared to C-carriers (CG/CC)(p=0.01). G-carriers were also more likely to have poorer survival compared to patients with CC genotype (p=0.04).Our results suggest that the Codon 72 polymorphism was not associated with the EC in eastern Turkey. However, GGgenotype (Arg/Arg) may have a role in tumor development at the lower location of the esophagus. Additionally, G carriersmay exist the poorer survival compared to the non-G carriers (CC). Therefore, it is thought that individuals with CCgenotype (Pro/Pro) may have better survival.

___

1. Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21: 7933-7943.

2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: 359-386.

3. Antonsson A, Nancarrow DJ, Brown IS, et al. High-risk human papilloma virüs in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 2080-2087.

4. Aysen TS. Epidemiology of esophagus cancer. J Exp Clin.Med 2012; 29: 203-208.

5. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat.Oncol 2007; 17: 38-44.

6. Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas J.N. Glickman, R.D. Odze (Eds.), Epithelial Neoplasm of the Esophagus (second ed.), Saunders, Philadephia, PA 2009; 535-563.

7. Abnett CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018; 154: 360-373.

8. Tang WR, Chen ZJ, Lin K, et al. Development of esophageal cancer in Chaoshan region, China: Association with environmental, genetic and cultural factors. Int J Hyg Environ Health 2015; 218: 12-18.

9. Umar M, Upadhyay R, Kumar S, et al. Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population. Tumour Biol 2014; 35: 11667-11676.

10. Chang J, Wei L, Miao X, et al. Two novel variants on 13q22.1 are associated with risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2015; 24: 1774-1780.

11. Levine DM, Ek WE, Zhang R, et al. A genomewide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett‘s esophagus. Nat Genet 2013; 45: 1487-1493.

12. Dumont P, Leu JI, Della Pietra AC 3rd, et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-365.

13. Das M, Sharma SK, Sekhon GS, et al. p16 gene silencing along with p53 singlenucleotide polymorphism and risk of esophageal cancer in Northeast India. Tumor Biol 2017; 39: 1010428317698384.

14. Peng JZ, Xue L, Liu DG, et al. Association of the p53 Arg72Pro polymorphism with esophageal cancer in Chinese populations: a meta-analysis. Genet Mol Res 2015; 14: 9024-9033.

15. Eltahir HA, Adam AA, Yahia ZA, et al. p53 Codon 72 arginine/ proline polymorphism and cancer in Sudan. Mol Biol Rep 2012; 39: 10833-10836.

16. Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a highrisk area of Iran. Br J Cancer 2008; 98: 1857-1863.

17. Wu M, Liu AM, Kampman E, et al. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case–control study. Int J Cancer 2009; 124: 1907-1913.

18. Andrici J, Eslick GD. Hot food and beverage consumption and the risk of esophageal cancer: a meta-analysis. Am J Prev Med 2015; 49: 952‐960.5.

19. Mwachiro MM, Parker RK, Pritchett NR, et al. Investigation tea temperature and content as risk factors for esophageal cancer in an endemic region of Western Kenya: Validation of a questionnaire and analysis of polycyclic hydrocarbon content. Cancer Epidemiol 2019; 60: 60-66.

20. Celik S, Yılmaz EM, Özden F, et al. The Relationship between Eating and Lifestyle Habits and Cancer in Van Lake Region: Another Endemic Region for Esophageal and Gastric Cancers. Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2015; 2015: 254823.

21. Pennathur A, Godfrey TE, Luketich JD. The molecular Biologic Basis of Esophageal and Gastric Cancers.Surg Clin North Am 2019; 9: 403-418.

22. Labuschagne CF, Zani F, Vousden KH. Control of metabolism by p53- Cancer and beyond Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2018; 1870: 32-42.

23. Hong Y, Miao X, Zhang X, et al. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Research 2005; 65: 9582-9587.

24. Jiang DK, Yao L, Wang WZ, et al. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. World Journal of Gastroenterology 2011; 17: 1227-1233.

25. Liu L, Wang K, Zhu ZM, et al. Associations between p53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Archives of Medical Research 2011; 42: 60-69.

26. Yang J, Liu B, Li W, et al. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). Cancer Epidemiol 2013; 37: 629-633.

27. Francisco G, Menezes PR, Eluf-Neto J, et al. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. International Journal of Cancer 2011; 129: 920-930.

28. Yang W, Zhang Y, Tian X, et al. p53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Molecular Carcinogenesis 2008; 47: 100-104.

29. Silveira APF, Manoel-Caetano FDS, Aoki S, et al. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. Anticancer Research 2011; 31: 1685- 1690.

30. Cescon DW, Bradbury PA, Asomaning K, et al. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clinical Cancer Research 2009; 15: 3103-3109.

31. Shao Y, TanW, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Diseases of the Esophagus 2008; 21: 139-143.

32. Cai L, Mu LN, Lu H, et al. Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiology Biomarkers and Prevention 2006; 15: 294-300.

33. Piao JM, Kim HN, Song HR, et al. p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study. Diseases of the Esophagus 2011; 24: 596-600.

34. Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus, International Journal of Cancer 2000; 89: 458-464.

35. Adduri RS, Katamoni R, Pandilla R, et al. TP53 Pro72 Allele Is Enriched in Oral Tongue Cancer and Frequently Mutated in Esophageal Cancer in India. PLoS ONE 2014; 9: e114002.

36. Hamajima N, Matsuo K, Suzuki T, et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Letters 2002; 181: 81-85.

37. Liu G, Cescon DW, Zhai R, et al. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma, Diseases of the Esophagus 2010; 23: 36-39.

38. Guimaraes DP, Lu SH, Snijders P, et al. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Letters 2001; 162: 231-235.

39. Lai KC, Chen WC, Tsai FJ, et al. Arginine and proline alleles of the p53 gene are associated with different of gastric cancer. Hepatogastroenterology 2005; 52: 944-948.

40. Renouf DJ, Zhai R, Sun B, et al. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma Journal of Gastroenterology and Hepatology 2013; 28: 1482-1488.
Eastern Journal of Medicine-Cover
  • ISSN: 1301-0883
  • Başlangıç: 1996
  • Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler

Endoscopic and Histopathological Findings, and The Presence of Helicobacter Pylori in Diabetic and NonDiabetic Patients Admitted to the Emergency Department with Dyspeptic Complaints

Mehmet Ali BİLGİLİ

The Effect of Infliximab on Oxidative Stress in Ovarian Tissue of the Rat with Ovarian Hyperstimulation Syndrome

Deniz DİRİK, Ahmet Ufuk KÖMÜROĞLU

Outcomes of The Modified Mcbride Procedure For Hallux Valgus: Analysis of The Radiographic Measurements

Emre BİLGİN

Abnormal First and Second Trimester Maternal Serum Marker Levels For Aneuploidy Screening and Adverse Pregnancy Outcomes

Lale SUSAN KARAKIŞ, Engin TURKGELDİ, Hüseyin KIYAK, Neşe YÜCEL

The Effect of Currant (Ribes) on Human Health and Determination Certain Antioxidant Activities

Mustafa BİLİCİ

Benign Gastric Outlet Obstruction Surgery: A Tertiary Center Experience

Ümit Haluk ILİKLERDEN, Mehmet Çetin KOTAN, Tolga KALAYCI

Hepatic Portal Venous Gas After Blunt Abdominal Trauma In A Child

Baran Serdar KIZILYILDIZ, Burhan BEGER, Oguzhan OZDEMİR

Reliability of Youtube Videos On Knee Joint Injection

Sezai ÖZKAN, Cihan ADANAŞ, Şeyhmus KAPLAN, Volkan ŞAH

Perineal Color Doppler Ultrasound of Periurethral Vascularization In Women Affected By Urinary Stress Incontinence

Sara MASCARETTİ, Carlo MASCİOCCHİ, Giulio MASCARETTİ, Eva FASCETTİ, Angela DALFONSO, Alessandro SERVA, Pietro CİGNİNİ, Michele FICHERA

The Association Between The Severity of Coronary Atherosclerosis and Abnormal Nocturnal Blood Pressure Variations in Hypertensive Patients

Remzi SARIKAYA, Ömer KÜMET